Calcineurin Inhibitor-Free Immunosuppressive Strategy in Elderly Recipients of Renal Allografts From Deceased Donors: 1-Year Results From a Prospective Single Center Trial

Transplantation Proceedings

Volumn 41, Issue 6, 2009, Pages 2529-2532

  Arbogast, H P ^a   Hoffmann, J N ^a   Illner, W D ^a   Hillebrand, G F ^a   Fischereder, M ^a   Jauch, K W ^a   Land, W ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATG FRESENIUS; BASILIXIMAB; CALCINEURIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; ELDERLY CARE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KIDNEY ALLOGRAFT; KIDNEY DONOR; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SINGLE DRUG DOSE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CADAVER; CALCINEURIN; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MYCOPHENOLIC ACID; PROSPECTIVE STUDIES; RABBITS; RECOMBINANT FUSION PROTEINS; SURVIVAL RATE; TIME FACTORS; TISSUE DONORS;

EID: 68949213652     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.151     Document Type: Article

References (10)

1. Arbogast H., Hückelheim H., Schneeberger H., et al. A Calcineurin antagonist-free induction/maintenance strategy for immunosuppression in elderly recipients of renal allografts from elderly cadaver donors: long-term results from a prospective single centre trial. Clin Transplant 19 (2005) 309
2. Guba M., Rentsch M., Wimmer C.D., et al. Calcineurin-inhibitor avoidance in elderly renal allograft recipients using ATG and basiliximab combined with mycophenolate mofetil. Transpl Int 21 (2008) 637
3. Nankivell B.J., Gruenewald S.M., Allen R.D., et al. Predicting glomerular filtration rate after kidney transplantation. Transplantation 59 (1995) 1683
4. Levey A.S., Green T., Kusek J.W., et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 11 (2000) 155A
5. EBPG Expert Group on Renal Transplantation: European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.13 Analysis of patient and graft survival. Nephrol Dial Transplant 17 suppl 4 (2002) 60
6. Zanker B., Schneeberger H., Rothenpieler U., et al. Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients. Transplantation 66 (1998) 44
7. Theodorakis J., Schneeberger H., Illner W.D., et al. Nephrotoxicity-free, mycophenolate mofetil-based induction/maintenance immunosuppression in elderly recipients of renal allografts from elderly cadaveric donors. Transplant Proc 32 (2000) 9S
8. Cho Y.W., and Terasaki P.I. Impact of new variables reported to the UNOS Registry. Clin Transpl 11 (1997) 305
9. Terasaki P.I., Gjertson D.W., Cecka J.M., et al. Significance of the donor age effect on kidney transplants. Clin Transplant 11 (1997) 366
10. Jorge S., Guerra J., Santana A., et al. Mycophenolate mofetil: ten years' experience of a renal transplant unit. Transplant Proc 40 (2008) 700